Life Science Disruptors →
Managing Director, D.E. Shaw and Co., L.P.
President and CEO of the Central Indiana Corporate Partnership
CEO of Project Foundry
Founder and Managing Director of DEV
VP of Research & Policy, Ewing Marion Kauffman Foundation
CEO of Dynamis Corporation
Co-Founder and CEO, Wetpaint
Nobel Laureate, Professor of Biology, Caltech
September 26, 2017 ·
September 28, 2017 ·
November 2, 2017 ·
Sponsored · Whitepaper
The pressure has never been greater for life science organizations to shorten the development cycle for new drugs and devices.
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
Reduce turnaround times, cut excessive admin expenses and increas
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.